You don’t need me to tell you half of the trading battle is timing. Owning a great company isn’t enough anymore - picking the right stocks at the right time is critical to making any real money in this business. With that in mind, three charts caught my eye in Monday.

One of them won’t surprise you a bit, and another won’t entirely surprise you….they’re both on our small cap stock watchlist. The third one is a first-mention (or first one a long time anyway) - a large cap biotech familiar to all of us.

I mentioned this a couple of times last week, but after seeing yesterday’s bullish effort it bears repeating - I have to wonder if Spicy Pickle (SPKL) is poised to pop.

The stock pulled back rather sharply last week, but it may have been just enough to convince the majority of traders that now’s not the time to be in. Of course, the best time to get into a stock is when it looks like nobody wants it….the way Spicy Pickle looked last week.

Like I said, it’s just a feeling. It’s a feeling I was feeling back in April too….before the upside move.

On a similar note, Bio-Matrix (BMSN) has put a pretty quick end to the pullback following its recent encounter with new 52-week highs. The peak of $1.29 on the 13th led to a low of 86 cents by the 24th. But, BMSN found footing again; now it’s trading at $1.00. This stock’s uptrend has been resilient.

Still no word on Bio-Matrix’s pending license inspection. It should be soon, if it hasn’t been completed yet. I’m pleasantly surprised to see the stock do as well as it has without that news in place. When-and-if they do get successfully licensed, I expect BMSN to really move….at least for a short time.

On that note though, I have to wonder if we should be thinking like short-term sellers shortly after any announcement from Bio-Matrix. The stock’s been a hot one, and at this point I’ll concede the possibility that getting the tissue bank license is already priced in. ‘Buy the rumor, sell the news’ is a cliche for a reason…as is the whole thing about a bird in the hand. Once the dust settles and the volatility is out of the way, then you can start looking for another entry point. I don’t want to miss a good exit opportunity though, even if only for the short term.

Just something to think about - we can cross that bridge when we come to it.

Now, about this large-cap biotech stock…

I’m not totally sold on the idea just yet, but I could be easiliy convinced that Amgen (AMGN) is positioned for a rally.

I’ve mentioned I like biotech a couple of times recently, and Amgen certainly falls right in the framework of that point of view. Though I’m still looking specifically for smaller biotech companies, I’m not going to pass up a good large cap opportunity.

The chart is the key for me. We’ve already seen AMGN work its way past a moderately significant resistance line. We’re also on the verge of seeing it move back above its 200 day moving average line….for the first time in over a year. If we see it happen, I’m in. I’ll let you know if it happens; we may even turn it into an official trade.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Most of you will know we’ve been paying close attention to micro cap stock Spicy Pickle (SPKL) over the last few days. A major support line at 83 cents was broken this week, and we watched SPKL sink to a low of 69 cents as a result. If that number rings a bell, it may be because that’s basically where the stock hit a low and rebounded in April.

The obvious question is, do we buy or sell here? My honest opinion is that this is a great opportunity to buy. That’s not to say it’s risk-free, but from my point of view this pullback is simply a washout of some selling that’s been ‘on the verge’ for a long time.

And just as a reminder, the same bearish arguments many folks are bound to be making now were also being made back on April 4th…right before the rebound to a peak of $1.01.

The other reason I’m far more apt to be a buyer than a seller here (in addition to a retest of a key support level) is the shape of the daily bars the last three days. Tuesday and Wednesday were fairly harsh, and on significant volume. Thursday was bullish - in the face of marketwide weakness - on slightly better volume.

It’s your call, but small cap and bulletin board stocks have a way of zigging just when it looks like they’re going to zag. I’m expecting the less obvious possibility to play out, based on my past experience.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

In case you didn’t see the chart yesterday, small cap stock pick Spicy Pickle (SPKL) finally broke under a key support line that had been in place since mid-April. It was roughly at 83 cents. SPKL had traded as low as 81 cents last week and early this week, which didn’t bother me too much since we never closed under 83 cents. On Tuesday though, too many owners were tired of waiting. The stock hit a low of 70 cents…..and came right back to close at 78 cents.

So, am I bullish, or bearish? Neither just yet, though based on the way the stock acted on an intra-day basis, I’m actually leaning towards bullishness…depending on what happens today.

That deep low - and subsequent recovery - may have been just what the doctor ordered….a flushout of all the Nervous Nellies, and a significant buy-back following the move to new multi-week lows. In other words, there were lots of sellers in the early half of the day, and then lots of buyers in the latter half of the day. (The shape of the say’s bar can tell you quiet a bit about the market’s psychology.)

That said, today’s the critical day. The bulls really need to follow-on from yesterday’s efforts and push SPKL at least a little higher today. If not, some more Nervous Nellies could use yesterday’s slight rebound as another exit opportunity…which is comparatively better than the low of 70 cents.

I’ll post more thoughts as needed here.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

I really thought this week’s news would get biotech stock CEL-SCI (CVM) moving again. And it did…..for a while. We saw little follow-through on the chart though. Even so, CEL-SCI is still one of our favorite longer-term ideas.

If you didn’t hear, CEL-SCI announced they’ve discovered an effective treatment for rheumatoid arthritis. They’re calling it CEL-2000 for now; it’s a vaccine/peptide that so far seems to be as effective - if not more effective - than the leading RA treatment. That’s not to say CEL-2000 is ready for the market. It’s got a lot more R&D to go, not to mention it has to pass the FDA’s requirements as well. But still, it’s something they feel confident enough about to keep working on. The rheumatoid arthritis market is no minor market either - it’s worth $13 billion per year.

Now, if the CEL-SCI news is only a little bit familiar to you, it may be because we’ve primarily focused on their cancer treatment Multikine. It’s also a vaccine, but obviously one with a much bigger impact on a market with much stronger demand. We haven’t been able to tell you much about Multikine’s progress lately because, well, there’s not much to report. The wrapped up Phase II testing last year, and will start Phase III testing later this year. Once this last round of trials gets underway, we’ll certainly have more to talk about.

The CEL-2000 announcement is equally good news…just different. Keep in mind, however, that Multikine is closer to the end of its developmental cycle, while CEL-2000 is practically at the beginning of its creation.

As for the stock, the last time I looked I was looking mostly at its range-boundedness (which I know is not a word, but you know what I’m saying). Here it is more than two months later, and the story is still the same despite a brief glimpse of bullishness on Tuesday…stuck between 65 and 70 cents. That’s still the key to getting this one going again - a break past 70 cents. Give it time.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

After the market closed last Thursday I mentioned how the Voyant International’s (VOYT) stock looked prime to reverse higher after retesting a key 61.8% retracement line (at 15 cents). Well, we did indeed see this small cap stock move higher on Friday. Today we’re seeing even more upside, this time with higher volume. That accumulation is still on the low side overall, but it’s enough to get the stock moving.

I’m not overly surprised either. As you can see for yourself, the degree of bearish volume was shrinking as the stock peeled back from the peak of 32 cents. I have to think that was profit-taking from those folks who don’t see the longer-term picture here (which is fine). Now with all the big swings out of the way, we can really start to hone in on a valuation. (For more on the volatility-versus-valuation theme, be sure to review Thursday’s blog.)

Anyway, just wanted to point out this small cap name may be gearing up for the second round - and maybe a breakout move.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

If you were in the trade, then you’re lovin’ today’s ride…and you’ll already know that Tenet Healthcare (THC) jumped 7% today on an upgrade from Lehman Brothers. They finally got on board…after the stock gained 70.9% from October’s low close. With today’s pop, we’re up about 40% on the stock pick.

Though it’s nice to get a little help, this changes nothing about what we’re seeing on the chart. This stock is volatile, but there’s been more bullish volatility than bearish volatility. THC shares have been bouncing around in a wide range, and we think they’re going to keep doing so until our objective of $7.67 is met.

In fact, today’s turn-around may have been jump-started by a sharp pullback in early June….a pullback that took the stock right back to the support line we discussed in our last mention of Tenet. Take a look at the chart - the blue support and resistance lines in particular. Now project where the upper line will be by the time it’s intercepted again. It looks like it will be pretty darn close to $7.67.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Small cap company Stockgroup Information Systems (SWEB) has taken another step in the advancement of financial content’s mobility. If you have a BlackBerry smartphone, you can now get real-time quotes, portfolio updates, news and more thanks to StockGroup’s StockStream Mobile data subscription service.

The product and platform was actually unveiled by Research in Motion (RIMM) at the Securities Industry and Financial Markets Association 2008 Technology Management Conference and Exhibit in New York City. Their booth obviously featured their BlackBerry, and all the things it could do for anyone involved in capital markets (like feed you StockGroup’s content and data). That’s not a bad audience to have your service featured in front of.

The data is robust too. Reuters is the supplier, feeding information from 40 different markets. That at least begins to address how StockGroup is going to start leveraging their relationship with Reuters (which has been in place for more than a year).

Here’s the really cool part though - StockStream Mobile can be ‘white labeled’ just like the regular web platform can. What’s that mean? It means if the brokers or other financial institutions want to resell StockStream Mobile as their own service, StockGroup can do that pretty easily. The platform and delivery doesn’t change; just the name and branding (and maybe color scheme)…which is pretty easy stuff to program.

Of course, StockGroup will get a piece of the revenue.

No word was given on the potential revenue the wireless data platform could generate. I don’t think it will be billions - at least not yet. But, it’s a good product…one I think investor-oriented companies will like and want to resell. The demand for mobility is only going to grow in the future, and StockGroup has been entrenching itself into the arena for quite some time.

If you want to see more about StockStream mobile, the StockGroup website is the place to go.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Did you see it? Did you see where our bulletin board stock pick SpongeTech Delivery Systems (SPNG) touched new multi-month highs today? OK, you probably didn’t. Visually, it’s almost imperceptible on a chart.

The stock hadn’t traded above 4.9 cents in months, though it had reached that high a handful of times in recent weeks. Today it actually reached 5 cents. I know what you’re thinking…it’s only a tenth of a cent. But hey - when you’re talking about a true penny stock, that’s a big deal.

On the other hand, SPNG didn’t stay there; it’s back to just under 4.9 cents now. But still, the ceiling is starting to crack.

The real story is still volume…which is also the reason I think breaking past 5 cents is inevitable. We’re gradually seeing accumulation bars (the green volume bars) get taller. At the same time, the bearish (red) volume bars are pretty short.

Bottom line - 5 cents is the line in the sand. Keep this one close.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

There are two things that immediately come to mind about our Tenet Healthcare (THC) stock pick (so far). The first is, it’s been profitable. The second thing is, it’s been one wild ride. The ups and downs have been wide enough to make a sailor seasick. Good news though….I think one more good runup like the last couple could get us to our target price of $7.67, and lock down an 89% gain.

Here’s my thinking….see the bullish ‘zone’ framed by a support and resistance line? We’re revisiting the support line right now, after an encounter with the resistance line in late April/early May. If you extend those out and ‘eyeball’ where THC is likely to be the next time that upper ceiling is met, that’s right around that level.

You can also see that’s a key resistance area from early 2007. No since in tempting fate beyond that point.

If the chart does indeed play out like that, it should happen sometime in late July.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

An e-mail we received today reminded me to remind all of you that we invite any and all inquiries. Our focus is small cap stocks, but if there’s a burning question all of our readers can learn from, send ‘em on. You can send us an e-mail, but if it’s just as easy, you’re always welcome to post a response to any blog entry. We’ll move it to an appropriate category, if need be. In the meantime, here’s today’s question about our coverage of small cap company SpongeTech (SPNG)….

Hi,
 
I’m an independent investor and find you blogs on Spongetech very interesting.
 
I had a few questions that I hoped you might be able to answer:
 
1) do you know the current shares outstanding and float?  It appears they’ve gone up about 400% since the end of last year?
 
2) based on their announcements, it looks like they sell their $19.99 kit for about $11.00 to distributors?
 
3) do you know their production capacity?   I understand they have a new warehouse, but was wondering how many units that can fulfill each quarter?
 
Thanks

Thanks for the question. No fanfare here - we’ll just answer them as straightforward as possible, and in order.

1. No, all we have is the same information you have, which is from the last 10Q. We’re showing 196 million shares outstanding. I’m not sure about 400% more from last year, but we do know they’re issuing shares to pay for marketing efforts.. At first I wasn’t a big fan of the practice, but I have to stay they’re making more per share than they’re diluting. So, I don’t have a problem with it. Besides, the market cap is still ridiculously low.
2. That’s about right. We ball-parked $10 per unit. Their actual cost, however, is much less. I don’t know specifics, but I’d guess less than half of that is their cost. That’s why margins are so good, and when the company really starts to crank it up, I’m looking for huge margins. That brings up a point worth making….retail versus wholesale. Their wholesale per-unit profit is probably around $7, while their retail profit (what they sell via their site) I think is closer to $17. The flipside is, they can sell a lot more via wholesale as opposed to retail. Retail is where the big bucks are though. You need both venues though…for the time being anyway.
3. I don’t know their production capacity, though I don’t think they’re capped yet. They outsource the manufacturing, and I get the feeling there’s no ceiling. The new inventory storage facility is adequate too. If you’re wondering why the big backlog versus current sales, that’s not SpongeTech’s doing….their customers (the vendors) don’t want delivery yet. They want those big quantities later. I don’t see capacity being a problem in terms if that $20 million+ backlog.

Hope that helps.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

This is why you get into a stock even when it doesn’t ‘feel’ perfect. Shares of small cap company Bio-Matrix Scientific Group (BMSN) are racing, up 33% today, and hitting new highs of 80 cents. Why? I was hoping it would be a pre-curser to a successful inspection from the California Health Department. I had forgotten they’re paying their preferred stock dividend tomorrow…as long as shareholder’s common shares were properly registered.

To receive the dividend, most owners just decided to push their shares out of margin accounts and into cash accounts. The result was that many - if not most - short positions have been ‘buying to cover’, as shares held in cash accounts can’t be loaned out to short. It’s akin to a margin call. The long-owners are the beneficiaries, and I doubt any short traders are interested in trying their hand again. That’s exactly what we wanted to see.

The upside is also technical; now that BMSN has broken out of a range and is at new monthly highs, other investors are likely to get interested.

The icing on the cake is that we still have the potential news about their licensing inspection. If that goes well, we’ll look for yet another pop in the stock.

The lesson to be learned? Sometimes you just have to get in the batter’s box and take a swing when the story is right. The other lesson to be learned….more often than not your friends at the Small Cap Network steer you in the right direction. BMSN is up 41% from where we picked it, and more inspiring news may be on the way.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Another $4.9 million in orders? Yep - small cap company SpongeTech Delivery Systems (SPNG) just announced a big order from three buyers…two in Central/South America, and one on the east coast of the United States. By my count, that brings the 12-18 month sales forecast up towards something around $27 million for SpongeTech. And, if my figures are anywhere close to being right, this latest salvo starts to put SPNG into radically undervalued territory. 

I estimated a backlog of $24 million in late April. We’ll add today’s $5 million order, and subtract a couple of million bucks for orders that were shipped in the meantime. Paring those future deliveries down to just twelve months rather than eighteen, I’d guess we’re looking at about $20 million in sales between now and May of next year.

Here’s the crazy part - the company’s present market cap is $8.2 million. Using a conservative rule-of-thumb price/sales ratio of 2.0, SPNG is undervalued by about 75%. You could try to argue that sales are nothing without earnings, but SpongeTech is also profitable as of last quarter (and pretty decisively profitable).

The stock is getting traction on the news, of course.

Though we’ve seen unfinished breakout attempts before from SPNG shares, this is one I’m not going to let up on. THE COMPANY IS GETTING RESULTS. The stock will eventually reflect them. As I’ve said several times now, getting past 5 cents is the key. Getting above 6 cents could be enormous.

In the bigger picture, it’s worth noting that the customers placing these orders include Winn-Dixie and Wal-Mart Mexico. I also found it interesting that the east coast merchants ordered 900 free-standing displays to prominently present the sponges in their store. That tells me they see an opportunity with the product, and are getting serious about getting them sold.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Excellent. I was worried that we’d see this small cap stock surge out of reach right out of the gate, but Voyant (VOYT) opened where it closed on Tuesday…at 12 cents. We are seeing a good deal of buying here, but I’ve yet to see a trade over 14 cents. In other words, this stock looks safe to venture into if you were worried about a lot of news-based volatility.

It looks like it’s going to be a high volume day as well. 244,000 shares have already traded hands, and we’re just nine minutes into the trading day. I expect today to be one of the biggest days ever for the stock in terms of volume, which should get the attention of anybody who may have missed the news (maybe some institutions too).

More importantly, I think this is going to jump-start the stock. I’m glad all of you were able to get in under 14 cents. Let’s just sit back and enjoy the ride.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Tally another one for this small cap company…Spicy Pickle (SPKL) has opened its 39th restaurant. This one’s close to home, in Fort Collins, Colorado. It’s the second company-owned store in Fort Collins, and if my math is correct, it’s the 6th company owned store. These stores offer more top and bottom line potential than a franchised store would.

This opening also pushes the company closer to operating profitability. When we first started covering their progress I guesstimated they’d start generating a positive cash flow with about 50 stores. That estimate was largely based on franchised units, but a handful of company-owned stores could bring the number of required stores down to the mid-40’s.

On that note, as spring turns into summer and construction is easier to do, I’m looking for the pace of store-openings to increase. We could see 50 stores by this fall.

The stock’s been in a bit of a funk the last several days, and didn’t even budge with today’s announcement. I suspect even though the news is good, investors ‘get it’….the company’s opening lots of restaurants. It doesn’t light a fire anymore. It’ll show up in the next quarterly filing though, which will light a fire.

If you’re in the area, the new restaurant is located at 2120 E. Harmony Rd., Unit 101, Ft. Collins, CO. As we’ve said from day one, we’re excited about this small cap investment based on the great food, which is the reason we’ve seen such rapid expansion. If you get a chance, go try the food and you’ll understand why for yourself. 

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Spongetech Delivery Systems (SPNG) has turned into a marketing juggernaut. What makes this small cap company different than other marketing juggernauts is that they’re spending $1 to make $2….not the other way around. Per today’s news release, now they’re on track to draw revenue from coast to coast (plus Alaska and Hawaii). How so? They’ve got a new television commercial, and it’s playing in all 50 states.

You might recall the company did pretty well with television spots a few weeks ago in select markets. Web traffic and sales both went up to all-time high levels, and the company posted its first decisive profit. In short, the ads (or something) worked. Now they’re taking the same strategy and deploying it on a wider scale. I suspect we’ll see the same proportional result.

If you haven’t seen the ad yet, the word is it’ll be on the company’s website pretty soon.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Small cap company Stockgroup Information Systems (OTCBB: SWEB) announced today part of their content feed from stockhouse.com will now be available on wireless devices through Viigo.

What’s Viigo? It’s an application that currently runs on Windows Mobile smart-phones and a Blackberry. The software is akin to a web browser, in that it aggregates the content you want to see on your device.

Stockgroup could already send market data to smart phones via their platform if the user had a MarketStream subscription. This latest addition to their technology offerings will open up Stockgroup’s free ‘News and Views’ feed to anyone who has Viigo.

I don’t know what kind of immediate impact this will have for the company. I don’t think it’s an overnight game-changer, but as the world becomes less and less wired (i.e. more and more wireless), I can see this making a decent dent. I just wish there was a way for the company to turn the service into immediate revenue. I’m sure as time passes though, some Viggo users are apt to take the next step and subscribe to the (revenue bearing) wireless service.

That being said, their wireless business was one of the items that didn’t get discussed at great length in last week’s conference call. I kind of wish it had, as the company has been devoting a lot of time and resources to that side of the business. Maybe next time.

If you weren’t able to make the conference call, you can catch a replay of it on the Stockgroup website. You may also want to read through my thoughts on their last quarter, which I posted in the blog.

As promised yesterday, today I’m going to deliver my post-conference-call thoughts on small cap Stockgroup Information Systems (SWEB). The company posted their Q1 earnings yesterday afternoon, but I wanted to reserve judgment until I heard what they had to say.

In short, I think whoever’s buying the stock today is making a mistake. SWEB is up 10% as of the time this us being written, and I congratulate the company for that. I can’t congratulate them for another tepid quarter though, this one with a widened loss.

To set the tone here, it just seems like we keep hearing ‘next quarter’ over and over again. (”Next quarter we’ll increase traffic, next quarter we’ll improve revenue, next quarter will shrink the loss, and next quarter we’ll cut expenses.”) My problem is, we’ve been hearing it for about four quarters now.

I’m not naive enough to think success happens overnight, but these guys have gotten into the habit of not delivering, or being flat wrong about critical elements of their business. 

The one that comes to mind from yesterday is expenses. They reported last quarter that the new website’s R&D was essentially ‘paid for’. In Q1, they pushed expenses up from $2.4 million to $3.6 million.

I don’t know if that was some lingering R&D expenses, or new stuff (the general/admin line shot from $1.0 million to $1.9 million though). It doesn’t entirely matter. I just remember last quarter they were touting all the new site expenses had been paid; they didn’t mention they’d offset those savings with other expenses.

In the conference call yesterday, they said they’d be saving $900K after terminating contracts with two vendors. It wasn’t clear if that was for the next quarter or the entire year, but it won’t matter if they spend the savings on something else…as they did this time around.

My other hot button is an ever-growing staff that’s not getting the results we were told to expect. All those sales and marketing gurus they hired? They were on board for all of Q1. Yet, I didn’t see any significant bump in the top line. All I saw was more payroll expenses.

To salt the wound, Stockgroup just diluted the float again with a $3 million financing. The market cap is only $17 million, meaning $3 million more has a big impact on current shareholders.

For those of you who have faithfully attended the conference calls and followed this company’s progress for nearly a year and half, you’ll probably understand my hesitation to be impressed now…it’s always something. I can’t wait to hear the next excuse. And no, I’m not buying in yet, no matter how much the chart looks like it’s turning around.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

The results are in for Stockgroup Information System’s (SWEB) quarter. The small cap company saw revenue increase by $400K. They pulled in $3.5 million in sales during Q1 of this year versus $3.1 million in sales for the same quarter a year earlier.

The biggest chunk of the improvement came from content licensing revenues. The company sold $2.6 million worth of their content service, up about $500K from licensing and subscription revenues in Q1 of 2007. Ad revenue was not quite flat; they did $875K this time around versus $925 a year ago.

The net loss for the quarter ended up being $1.4 million versus the $550K loss from Q1, 2007. Costs for each category increased proportionally to the prior Q1, except for general and administrative. Several new hires between then and now pushed the general/admin expense line up to $1.9 million from the $1.0 million spent in the first quarter of last year.

All in all, their results were pretty much in line with the market’s expectations.

Now, to get the real scoop, the best thing to do is dial in to the conference call being hosted at 4:05 p.m. EST today. To participate in the conference call, please call 1-866-400-3310 five to ten minutes prior to the start time.

Or, if you’re more of a web-based investor, you can listen to the live webcast. Just go to www.stockgroup.com and look for the webcast link.

As always, we’ve found conference calls offer the much-needed perspective behind the numbers. The Stockgroup calls have traditionally been outstanding sources for ‘the story behind the story’. Whether it is again this time or now depends on the questions asked, which is why we encourage you to dial in and ask about the important stuff.

Most importantly, the call may help define the future for the company. Some of the things we’d like to see get fleshed out in the call…

• What’s the plan for improving ad revenue now that all these sales/marketing people are in place?
• Can we expect to see expenses stay this high going forward?
• What’s the marketing plan to grow the website now that the final version is up and running?
• Above all else, what kind of dollars is the company projecting in the near and long-term (for all lines of the income statement)?

I’ve got some thoughts on the numbers above, but before I pass judgment I want to get on the call and see what else is said. Check back tomorrow for my full opinion. In the meantime, I suggest getting on the call.

Oh, and here’s the official quarterly results from Stockgroup.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

We already mentioned this a few days ago, but if you and your 12-or-under kid happen to be heading to Shea Stadium tonight to watch the Mets play the Washington Nationals, you might want to get their before 7:10 p.m.

Why? Tonight is SpongeTech Delivery System’s (SPNG) ‘Promotional Day’. The first 12,000 kids age 12 or under will receive a T-shirt commemorating Shea Stadium.

While any publicity is good, the word is the upside to being a game sponsor has already started. SpongeTech reports their website’s traffic has more than tripled since the radio ads and ancillary mentions - part of the sponsorship package - started a few day ago.

I don’t think that’s why this bulletin board stock pick is perking up again today though, following yesterday’s sleepy session. I think it’s up today because there’s a bigger trend now in place…one where the stock actually reflects its value. (It does happen every now and then ya’ know.)

As before, anything at or above 5 cents would represent higher highs, and possibly a rally effort. If it takes off, a revisit to 12 cents isn’t out of the question. That was our original price target for this small cap stock pick, and we’re sticking to it.

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.

Though we’ve only got a couple of trading days under our belt since we mentioned bulletin board stock Voyant International (VOYT), they’ve been a good two days. Shares closed at 10 cents on Thursday - the day we issued our company profile in the newsletter. As of right now, they’re at 12.5 cents…up 25% since our first look.

Even more compelling is the volume. We’re seeing a significant amount of buying now.

The short-term line in the sand seems to be 13.5 cents. We saw VOYT peak there yesterday, not to mention peaking at that line a couple other times earlier in the year. If the stock can break past that resistance, I really like the odds of a rally. I’d be accumulating on that breakout.

On the chart below you see a peak around 38 cents. What you don’t see is the peak of 76 cents from the middle of last year. Those are my short-term and longer-term mental goals.

Are they acheivable? I think so, though we’re not going to put VOYT in a full-blown ‘trade’ framework just yet. All I know is this company’s market cap is a mere $14 million, and they’re looking at a handful of multi-million dollar deals.

In the meantime, I think this bulletin board pick is starting to get traction, reflecting the underlying company’s potential.  

Are you a subscriber to the Small Cap Network newsletter? If not, you’re missing out on some great trading ideas and exclusive market commentary. To sign up, just go to the top right corner of any page of our website. You’ll be joining thousands of other subscribers who have already benefited from our news and views.